Records containing: Neuroendocrine Tumors
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-12-15A Phase II, Open-label, Multicentre, Randomised Study of the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of CAM2029 in Patients With Acromegaly and Neuroendocrine Tumours (NETs) Previously Treated With Sandostatin® LAR®
-
CLINICAL_TRIALS study record update · 2017-12-13Psychosocial Screening for Neuroendocrine Tumor Patients
-
CLINICAL_TRIALS study record update · 2017-10-19A Ph 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic PNET or GI-NET Neuroendocrine Tumors/Carcinoid With Elevated Biomarkers
-
CLINICAL_TRIALS study record update · 2017-10-12Safety and Dosimetry of a Long-lasting Radiolabeled Somatostatin Analogue 177Lu-DOTA-EB-TATE in Patients With Advanced Metastatic Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2017-09-20A Prospective Exploration in the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-09-12A Randomized, Controlled Phase II Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor
-
CLINICAL_TRIALS study record update · 2017-08-25Prospective Longitudinal Biomarker Study in Pancreatic Neuroendocrine Tumours
-
CLINICAL_TRIALS study record update · 2017-08-04Development of an Innovative Gallium 68 Radiolabeling of DOTATOC (68Ga-DOTATOC) for PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation
-
CLINICAL_TRIALS study record update · 2017-07-17A Phase II Trial of Panobinostat in Patients With Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2017-06-14Phase II Clinical Study on Proton Therapy Boost (Hadrontherapy) for Locally Advanced HEAD AND NECK TUMORS
-
CLINICAL_TRIALS study record update · 2017-05-03Safety and Efficacy Study of 68Ga-Dotatoc Positron Emission Tomography for Diagnosis for Staging, Restaging and Assessment of Response to Treatment in Somatostatin Receptor-Positive Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2017-05-03A Phase II Clinical and Biological Study of Lithium Carbonate in Patients With Low-Grade Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2017-04-17A Phase 2a Intrapatient Dose Escalation Study of Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2017-03-21Best Therapy for Patients With Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2017-03-03A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2017-03-01EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2017-01-30Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
-
CLINICAL_TRIALS study record update · 2016-12-28A Randomized, Double-blind, Multicenter, Phase III Study of Everolimus (RAD001) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced NET of GI or Lung Origin
-
CLINICAL_TRIALS study record update · 2016-11-08Gallium-68 DOTATOC for Management of Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2016-11-0268Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial
-
CLINICAL_TRIALS study record update · 2016-07-21Combination Targeted Radiotherapy in Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2016-07-20Identification of Biomarker Profiles for Individualized Prognostic Stratification and Therapy in Patients With Gastroenteropancreatic Neuroendocrine Neoplasia (GEP-NEN)
-
CLINICAL_TRIALS study record update · 2016-06-22Phase II Study of Capecitabine and Temozolomide for Progressive, Differentiated, Metastatic Neuroendocrine Cancers
-
CLINICAL_TRIALS study record update · 2016-05-06Randomized Phase 3 Trial Evaluating the Efficacy of Locoregional Treatment With Transarterial Embolization (TAE) for Liver Metastases, in Combination With Pharmacotherapy, in Patients With Neuroendocrine Tumor and Inoperable Liver Metastasis.
-
CLINICAL_TRIALS study record update · 2016-03-30A Multi-centric, Open-label, Phase II Study Investigating the Combination of Afinitor With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced (Stage IV) Large Cell Lung Cancer With Neuroendocrine Differentiation (LC-NEC)